Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study
- PMID: 27845908
- PMCID: PMC5355263
- DOI: 10.18632/oncotarget.13298
Endoscopic versus laparoscopic resection of gastric gastrointestinal stromal tumors: a multicenter study
Abstract
Despite endoscopic resection has been performed to treat gastric gastrointestinal stromal tumor (GISTs). However, the safety and long-term outcomes remains controversial. This study aims to compare the safety and surgical outcomes of endoscopic versus laparoscopic resection of gastric GISTs. A total of 335 patients that were pathologically confirmed with gastric GISTs (tumor size ≤ 3.5 cm) were surgically treated with endoscopic resection (endoscopic group) or laparoscopic resection (laparoscopic group) in three institutions from March 1, 2011 to October 1 2014. These demographics, tumor characteristics, and outcomes were retrospectively analyzed for identification of outcomes and feasibility of endoscopic or laparoscopic resection. Of 335 patients, 262 and 73 patients underwent endoscopic and laparoscopic resection, respectively. The average tumor size was 1.33±0.78 cm in the endoscopic group and 1.97±0.93 cm in the laparoscopic group. The average operating time was 62.40±36.94 min in the endoscopic group and 112.81±55.69 cm in the laparoscopic group. Days of realimentation was 2.76±1.67 in the endoscopic group and 4.89±2.03 in the laparoscopic group. The average cost was $ 3246.01±1017.61 in the endoscopic group and $ 4884.81±1339.51 in the laparoscopic group. There was no postoperative mortality. Endoscopic resection for gastric GISTs is safe and feasible in tumors ≤ 3.5 cm. Because endoscopic resection showed good results with lower operating time, realimentation days, length of hospital stay and mean total cost, it is a minimally invasive and safe alternative approach which can achieve fast recovery and satisfactory outcomes for appropriately selected patients with gastric GISTs.
Keywords: endoscopic; gastric GISTs; laparoscopic; minimally invasive; resection.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures


Similar articles
-
Minimally invasive treatment of laparoscopic and endoscopic cooperative surgery for patients with gastric gastrointestinal stromal tumors.J Dig Dis. 2013 Sep;14(9):469-73. doi: 10.1111/1751-2980.12076. J Dig Dis. 2013. PMID: 23701957
-
Laparoscopic and endoscopic cooperative surgery is a feasible treatment procedure for intraluminal gastric gastrointestinal stromal tumors compared to endoscopic intragastric surgery.Surg Endosc. 2018 Jan;32(1):351-357. doi: 10.1007/s00464-017-5683-x. Epub 2017 Jun 29. Surg Endosc. 2018. PMID: 28664426
-
Minimally invasive treatment of gastric gastrointestinal stromal tumors: laparoscopic and endoscopic approach.Surg Laparosc Endosc Percutan Tech. 2012 Jun;22(3):244-50. doi: 10.1097/SLE.0b013e31825078f2. Surg Laparosc Endosc Percutan Tech. 2012. PMID: 22678321
-
Long-term outcomes of treatment of gastric gastrointestinal stromal tumor by laparoscopic surgery: review of the literature and our experience.Hepatogastroenterology. 2013 Nov-Dec;60(128):2011-5. Hepatogastroenterology. 2013. PMID: 24719942 Review.
-
Effectiveness and safety of endoscopic resection for gastric GISTs: a systematic review.Minim Invasive Ther Allied Technol. 2018 Jun;27(3):127-137. doi: 10.1080/13645706.2017.1347097. Epub 2017 Jul 6. Minim Invasive Ther Allied Technol. 2018. PMID: 28681655
Cited by
-
Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach.Gut Liver. 2023 Mar 15;17(2):217-225. doi: 10.5009/gnl210454. Epub 2023 Feb 15. Gut Liver. 2023. PMID: 36789572 Free PMC article.
-
Endoscopic Resection for Gastric Subepithelial Tumor with Backup Laparoscopic Surgery: Description of a Single-Center Experience.J Clin Med. 2021 Sep 27;10(19):4423. doi: 10.3390/jcm10194423. J Clin Med. 2021. PMID: 34640444 Free PMC article.
-
Is endoscopic resection better than laparoscopic resection for gastric gastrointestinal stromal tumors?J Gastrointest Oncol. 2023 Aug 31;14(4):1894-1895. doi: 10.21037/jgo-23-137. Epub 2023 Jul 7. J Gastrointest Oncol. 2023. PMID: 37720429 Free PMC article. No abstract available.
-
Risk factors for conversion from endoscopic resection to laparoscopic resection for gastric gastrointestinal stromal tumors.J Int Med Res. 2023 Apr;51(4):3000605231167796. doi: 10.1177/03000605231167796. J Int Med Res. 2023. PMID: 37077159 Free PMC article.
-
Efficiency of an endoscopic resection strategy for management of submucosal tumors < 20 mm in the upper gastrointestinal tract.Endosc Int Open. 2022 Apr 14;10(4):E347-E353. doi: 10.1055/a-1783-8675. eCollection 2022 Apr. Endosc Int Open. 2022. PMID: 35433227 Free PMC article.
References
-
- Zhuang C, Wang M, Qiu WQ, Xu J, Shen ZY, Cao H. [Clinicopathological features and management of gastrointestinal stromal tumors complicated with synchronous other alimentary malignant tumor] Zhonghua Wei Chang Wai Ke Za Zhi. 2013;16:234–238. - PubMed
-
- Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. LANCET ONCOL. 2002;3:655–664. - PubMed
-
- Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad TG, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. SCIENCE. 1998;279:577–580. - PubMed
-
- Nilsson B, Bumming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. CANCER-AM CANCER SOC. 2005;103:821–829. - PubMed
-
- Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. HUM PATHOL. 2008;39:1411–1419. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical